Articles with public access mandates - William L CarrollLearn more
Not available anywhere: 9
NT5C2 germline variants alter thiopurine metabolism and are associated with acquired NT5C2 relapse mutations in childhood acute lymphoblastic leukaemia
M Tulstrup, M Grosjean, SN Nielsen, K Grell, BO Wolthers, PS Wegener, ...
Leukemia 32 (12), 2527-2535, 2018
Mandates: US National Institutes of Health
Beating the clock in T-cell acute lymphoblastic leukemia
WL Carroll, I Aifantis, E Raetz
Clinical Cancer Research 23 (4), 873-875, 2017
Mandates: US National Institutes of Health
Palbociclib in combination with chemotherapy in pediatric and young adult patients with relapsed/refractory acute lymphoblastic leukemia and lymphoma: A Children's Oncology …
EA Raetz, DT Teachey, C Minard, X Liu, RE Norris, KZ Denic, J Reid, ...
Pediatric Blood & Cancer 70 (11), e30609, 2023
Mandates: US National Institutes of Health
Feasibility of monitoring peripheral blood to detect emerging clones in children with acute lymphoblastic leukemia†
J Saliba, NA Evensen, JA Meyer, D Newman, J Nersting, S Narang, X Ma, ...
Pediatric Blood & Cancer 67 (7), e28306, 2020
Mandates: US National Institutes of Health
Activation of the mitogen‐activated protein kinase–extracellular signal‐regulated kinase pathway in childhood B‐cell acute lymphoblastic leukemia
PM Pillai, N Mallory, J Pierro, J Saliba, D Newman, J Hu, T Bhatla, ...
Pediatric Blood & Cancer 69 (10), e29771, 2022
Mandates: US National Institutes of Health, Alex's Lemonade Stand
Minimal residual disease predicts outcomes in KMT2A‐rearranged but not KMT2A‐germline infant acute lymphoblastic leukemia: Report from Children's Oncology …
KE Faulk, JA Kairalla, ZAE Dreyer, AJ Carroll, NA Heerema, M Devidas, ...
Pediatric blood & cancer 70 (9), e30467, 2023
Mandates: US National Institutes of Health
The potential of precision medicine for childhood acute lymphoblastic leukemia: opportunities and challenges
N Mallory, J Pierro, E Raetz, WL Carroll
Expert Review of Precision Medicine and Drug Development 3 (6), 343-356, 2018
Mandates: US National Institutes of Health
Epigenetic Dysregulation in Pediatric Leukemia
PP Madhusoodhan, WL Carroll, T Bhatla
Epigenetic Mechanisms in Cancer, 1-30, 2018
Mandates: US National Institutes of Health
Reply to A. Bleyer et al
SP Hunger, X Lu, M Devidas, BM Camitta, PS Gaynon, NJ Winick, ...
Journal of Clinical Oncology 30 (32), 4038-4039, 2012
Mandates: US National Institutes of Health
Available somewhere: 188
Deletion of IKZF1 and Prognosis in Acute Lymphoblastic Leukemia
CG Mullighan, X Su, J Zhang, I Radtke, LAA Phillips, CB Miller, J Ma, ...
New England Journal of Medicine 360 (5), 470-480, 2009
Mandates: US National Institutes of Health
Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia
KG Roberts, Y Li, D Payne-Turner, RC Harvey, YL Yang, D Pei, ...
New England journal of medicine 371 (11), 1005-1015, 2014
Mandates: US National Institutes of Health
Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group
SP Hunger, X Lu, M Devidas, BM Camitta, PS Gaynon, NJ Winick, ...
Journal of clinical oncology 30 (14), 1663-1669, 2012
Mandates: US National Institutes of Health
Biology, risk stratification, and therapy of pediatric acute leukemias: an update
CH Pui, WL Carroll, S Meshinchi, RJ Arceci
Journal of clinical oncology 29 (5), 551-565, 2011
Mandates: US National Institutes of Health
Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study
MJ Borowitz, M Devidas, SP Hunger, WP Bowman, AJ Carroll, WL Carroll, ...
Blood, The Journal of the American Society of Hematology 111 (12), 5477-5485, 2008
Mandates: US National Institutes of Health
The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia
Y Liu, J Easton, Y Shao, J Maciaszek, Z Wang, MR Wilkinson, ...
Nature genetics 49 (8), 1211-1218, 2017
Mandates: US National Institutes of Health
Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia
KG Roberts, RD Morin, J Zhang, M Hirst, Y Zhao, X Su, SC Chen, ...
Cancer cell 22 (2), 153-166, 2012
Mandates: US National Institutes of Health, National Health and Medical Research …
Improved early event-free survival with imatinib in Philadelphia chromosome–positive acute lymphoblastic leukemia: A children's oncology group study
KR Schultz, WP Bowman, A Aledo, WB Slayton, H Sather, M Devidas, ...
Journal of Clinical Oncology 27 (31), 5175-5181, 2009
Mandates: US National Institutes of Health
JAK mutations in high-risk childhood acute lymphoblastic leukemia
CG Mullighan, J Zhang, RC Harvey, JR Collins-Underwood, ...
Proceedings of the National Academy of Sciences 106 (23), 9414-9418, 2009
Mandates: US National Institutes of Health, Howard Hughes Medical Institute
Rearrangement of CRLF2 in B-progenitor– and Down syndrome–associated acute lymphoblastic leukemia
CG Mullighan, JR Collins-Underwood, LAA Phillips, MG Loudin, W Liu, ...
Nature genetics 41 (11), 1243-1246, 2009
Mandates: US National Institutes of Health
Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children's Oncology Group study
K Nguyen, M Devidas, SC Cheng, M La, EA Raetz, WL Carroll, NJ Winick, ...
Leukemia 22 (12), 2142-2150, 2008
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program